Stocks and Investing
Stocks and Investing
Mon, September 16, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Reiterated (BCYC) at Strong Buy and Held Target at $38 on, Sep 16th, 2024
Ami Fadia of Needham, Reiterated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $38 on, Sep 16th, 2024.
Ami has made no other calls on BCYC in the last 4 months.
There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Wednesday, August 7th, 2024
These are the ratings of the 3 analyists that currently disagree with Ami
- Li Watsek of "Cantor Fitzgerald" Reiterated at Buy on, Monday, September 9th, 2024
- Gregory Renza of "RBC Capital" Initiated at Buy and Held Target at $35 on, Friday, September 6th, 2024
- Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $48 on, Wednesday, August 7th, 2024
Contributing Sources